Liv Johannessen, P.h.D. Syros Pharmaceuticals discusses Activity of SY-5609 an oral noncovalent potent and selective CDK7 inhibitor in preclinical models of colorectal cancer
https://meetinglibrary.asco.org/record/188034/abstract
ASCO2020
Activity of SY-5609 an oral noncovalent potent and selective CDK7 inhibitor in preclinical models of colorectal cancer – Liv Johannessen P.h.D. Syros Pharmaceuticals @SyrosPharma #colorec…
